title: Beta-agonists.
abstract: Beta-Agonists are a mainstay of asthma treatment. Short-acting beta-agonists are the most effective bronchodilators for rescue or quick relief of symptoms. Long-acting beta-agonists have a key role in long-term control when added to inhaled corticosteroid therapy, and are especially useful in the control of nocturnal asthma. Both types of beta-agonists may be used in the prophylaxis of exercise-induced asthma with long-acting beta-agonists providing more prolonged protection. beta-Agonists have minimal side effects and are safe when used appropriately.
authors.affiliation: Division of Allergic Diseases and Internal Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA.
authors.forename: Ellen J
authors.initials: EJ
authors.lastname: Dutta
authors.forename: James T C
authors.initials: JT
authors.lastname: Li
mesh_terms: D000318:Adrenergic beta-Agonists / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D006801:Humans
chemical_list: D000318:Adrenergic beta-Agonists